BioLife Solutions Inc. vs. electroCore, Inc. Common Stock
BioLife Solutions Inc. and electroCore, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BLFS | ECOR | |
|---|---|---|
| Market Cap | $1.77 billion | $102.60 million |
| Revenue (TTM) | $102.82 million | $36.97 million |
| Net Income (TTM) | $57.98 million | $-14,770,000 |
BLFS leads on 3 of 3 size & scale factors.
Valuation
| BLFS | ECOR | |
|---|---|---|
| P/E Ratio | 30.60 | — |
| Price / Book | 4.21 | -36.77 |
| Price / Sales | 17.18 | 2.78 |
ECOR leads on 2 of 2 valuation factors.
Profitability
| BLFS | ECOR | |
|---|---|---|
| Net Margin | 56.39% | -39.96% |
| Return on Equity | 13.80% | 529.39% |
BLFS and ECOR split the profitability factors evenly.
Risk & Sentiment
| BLFS | ECOR | |
|---|---|---|
| Short Interest | 1.61% | 0.22% |
ECOR leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLFS overview, BLFS financials, ECOR overview, ECOR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.